Chemistry:Imocitrelvir
From HandWiki
Imocitrelvir is an investigational new drug that is being evaluated for the treatment of viral infections. It is a 3C protease inhibitor in picornaviruses. Originally developed by Pfizer for treating human rhinovirus infections,[1] this small molecule has shown promise against a broader range of viruses, including polioviruses.[2][3]
References
- ↑ "Imocitrelvir". PatSnap. https://synapse.patsnap.com/drug/4844b989465b43bea1f141512a4407b4.
- ↑ "Antiviral Development for the Polio Endgame: Current Progress and Future Directions". Pathogens (Basel, Switzerland) 13 (11): 969. November 2024. doi:10.3390/pathogens13110969. PMID 39599522.
- ↑ "Polio Eradication: Status, Struggles and Strategies.". The Pediatric Infectious Disease Journal 43 (6): e207-211. June 2024. doi:10.1097/INF.0000000000004330. PMID 38564755.
 |  |
